APOTHEKER-BIOLOOG H. CLEEMPUT
0457.709.742 · rovalta.com · 26/09/2026
NORMAL SITUATION
APOTHEKER-BIOLOOG H. CLEEMPUT
Company — Normal situation.
Financial year 2023 · Closed on 30/06/2023
Net result133,7 k €-57,3 %over 1 year
Gross margin199,6 k €-54,5 %over 1 year
Equity822,3 k €+19,4 %over 1 year
Overview
Identity
Source · BCE/KBOAPOTHEKER-BIOLOOG H. CLEEMPUT is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0457.709.742
- Legal form
- Private company with limited liability
- Contributed capital
- 18 592,01 €
- Latest accounts
- 30/06/2023
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 27 filingsTrend over 11 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 199,6 k € | -54.5% | 438,3 k € | +42.2% | 308,2 k € | +101% | 153,4 k € | +114% | 71,8 k € |
| EBITDA | 199,1 k € | -54.5% | 437,6 k € | +42.1% | 308,1 k € | +101% | 153,3 k € | +114% | 71,6 k € |
| Operating result | 193,1 k € | -55.3% | 432,1 k € | +44.8% | 298,4 k € | +107% | 144,3 k € | +215% | 45,9 k € |
| Net result | 133,7 k € | -57.3% | 312,6 k € | +53.2% | 204,1 k € | +107% | 98,7 k € | +199% | 33 k € |
| Balance sheet | |||||||||
| Equity | 822,3 k € | +19.4% | 688,7 k € | +83.1% | 376 k € | +119% | 172 k € | +135% | 73,2 k € |
| Total assets | 838 k € | +16.3% | 720,7 k € | +64.9% | 437 k € | +81.0% | 241,5 k € | +92.5% | 125,4 k € |
| Cash | 534 k € | +53.1% | 348,8 k € | +38.5% | 251,8 k € | +54.7% | 162,8 k € | +494% | 27,4 k € |
| Debts | 12,3 k € | -61.6% | 32 k € | -47.5% | 61 k € | -12.3% | 69,5 k € | +33.2% | 52,2 k € |
Board of directors
Source · NBB, accounts to 30/06/20231 active · 1 ended
Active mandates
Hugo Cleemput
ActiveEnded mandates
Hugo Cleemput
EndedFinancials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 | 01/07/2018 | 01/07/2017 |
| Closing of the financial year | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 30/06/2019 | 30/06/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/01/2024 | 27/01/2023 | 28/01/2022 | 27/01/2021 | 03/01/2020 | 30/01/2019 |
| General meeting | 17/11/2023 | 31/12/2022 | 31/12/2021 | 30/12/2020 | 16/12/2019 | 29/11/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 27 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2023 | 17/11/2023 | 31/01/2024 | Dutch | |
| Micro model | 30/06/2022 | 31/12/2022 | 27/01/2023 | Dutch | |
| Micro model | 30/06/2021 | 31/12/2021 | 28/01/2022 | Dutch | |
| Micro model | 30/06/2020 | 30/12/2020 | 27/01/2021 | Dutch | |
| Micro model | 30/06/2019 | 16/12/2019 | 03/01/2020 | Dutch | |
| Micro model | 30/06/2018 | 29/11/2018 | 30/01/2019 | Dutch | |
| Micro model | 30/06/2017 | 30/11/2017 | 22/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 01/12/2016 | 23/12/2016 | Dutch | |
| Abridged model | 30/06/2015 | 10/12/2015 | 29/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 27/11/2014 | 22/12/2014 | Dutch | |
| Abridged model | 30/06/2013 | 28/11/2013 | 30/01/2014 | Dutch | |
| Abridged model | 30/06/2012 | 29/11/2012 | 29/01/2013 | Dutch | |
| Abridged model | 30/06/2011 | 07/12/2011 | 19/12/2011 | Dutch | |
| Abridged model | 30/06/2010 | 25/11/2010 | 13/12/2010 | Dutch | |
| Abridged model | 30/06/2009 | 26/11/2009 | 30/11/2009 | Dutch | |
| Abridged model | 30/06/2008 | 27/11/2008 | 13/01/2009 | Dutch | |
| Abridged model | 30/06/2007 | 29/11/2007 | 22/01/2008 | Dutch | |
| Abridged model | 30/06/2006 | 30/11/2006 | 27/12/2006 | Dutch | |
| Abridged model | 30/06/2005 | 24/11/2005 | 29/11/2005 | Dutch | |
| Abridged model | 30/06/2004 | 25/11/2004 | 29/11/2004 | Dutch | |
| Abridged model | 30/06/2003 | 27/11/2003 | 23/01/2004 | Dutch | |
| Abridged model | 30/06/2002 | 28/11/2002 | 02/12/2002 | Dutch | |
| Abridged model | 30/06/2001 | 29/12/2001 | 17/01/2002 | Dutch | |
| Abridged model | 30/06/2000 | 30/11/2000 | 19/01/2001 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20231 active · 1 ended
Active mandates
Hugo Cleemput
ActiveEnded mandates
Hugo Cleemput
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023133,7 k €↓
- 2022Annual accounts 2022312,6 k €↑
- 2021Annual accounts 2021204,1 k €↑
- 2020Annual accounts 202098,7 k €↑
- 2019Annual accounts 201933 k €↓
- 2018Annual accounts 201833,6 k €↑
- 2017Annual accounts 2017-22,1 k €↓
- 2016Annual accounts 201612,3 k €↓
- 2015Annual accounts 201522,3 k €↑
- 2014Annual accounts 2014-13,8 k €↓
- 2013Annual accounts 201314,7 k €